nach oben

Reactions Weekly

Erschienen in:

01.06.2022 | Case report

Ad26.COV2-S/elasomeran/tozinameran

Splanchnic vein thrombosis and thrombosis at multiple unusual sites: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Patient demographics (elderly man) were obtained through direct communication with the author.

Abbattista M, et al. Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites. Journal of Thrombosis and Haemostasis 19: 2554-2558, No. 10, Oct 2021. Available from: URL: http://doi.org/10.1111/jth.15493

Titel: Ad26.COV2-S/elasomeran/tozinameran
Splanchnic vein thrombosis and thrombosis at multiple unusual sites: 3 case reports
Publikationsdatum: 01.06.2022
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-16850-0

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Ad26.COV2-S/elasomeran/tozinameran

Splanchnic vein thrombosis and thrombosis at multiple unusual sites: 3 case reports

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Bendamustine

Amphotericin-B-liposomal/prednisone/voriconazole

Rituximab

Doxorubicin

Ciprofloxacin/warfarin interaction

Tetrabenazine